Wolfgang Marguerre
Vorstandsvorsitzender bei Octapharma AG
Vermögen: 226 Mio $ am 30.04.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Tobias Marguerre | M | 53 |
Octapharma Nordic AB
Octapharma Nordic AB Pharmaceuticals: MajorHealth Technology Octapharma Nordic AB specializes in the production and distribution of plasma derivative. Its products are used for the treatment in coagulation disorders, immune disease and intensive care and emergency medicine. The company is headquartered in Stockholm, Sweden
Octapharma AB
Octapharma AB Pharmaceuticals: MajorHealth Technology Octapharma AB manufactures and distributes pharmaceutical products. Its products used for treatment in coagulation disorders, immune disease, and intensive care and emergency medicine. The company operates as a subsidiary of Octapharma AG. Octapharma was founded in 1997 and is located in Stockholm, Sweden. | - |
Nicholas Jacobson | M | - |
Octapharma AG
Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland. | - |
Krister Lenberg | M | - |
Octapharma AB
Octapharma AB Pharmaceuticals: MajorHealth Technology Octapharma AB manufactures and distributes pharmaceutical products. Its products used for treatment in coagulation disorders, immune disease, and intensive care and emergency medicine. The company operates as a subsidiary of Octapharma AG. Octapharma was founded in 1997 and is located in Stockholm, Sweden. | - |
Roger Mächler | M | - |
Octapharma AG
Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland. | - |
Cornelius Marguerre | M | 66 |
Octapharma Ltd.
Octapharma Ltd. BiotechnologyHealth Technology Part of Octapharma AG, Octapharma Ltd. is a British company that manufactures human protein products. The company is based in Manchester, UK. Octapharma was founded in 1983. | - |
Flemming Nielsen | M | - |
Octapharma USA, Inc.
Octapharma USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Octapharma AG, Octapharma USA, Inc. develops and manufactures medicines for hematology, immunotherapy, and critical care patients. The company is based in Paramus, NJ. | - |
Johannes Oafer | M | - |
Octapharma Gmbh
Octapharma Gmbh Pharmaceuticals: MajorHealth Technology Octapharma GmbH specializes in the development and manufacture of preparations from human plasma. It focuses on virus-inactivated drugs for the treatment of diseases in the fields of immunology, hemophilia and Iten sivmedizin. The company was founded in 1983 and is headquartered in Langenfeld, Germany. | - |
Johannes Hafer | M | - |
Octapharma Gmbh
Octapharma Gmbh Pharmaceuticals: MajorHealth Technology Octapharma GmbH specializes in the development and manufacture of preparations from human plasma. It focuses on virus-inactivated drugs for the treatment of diseases in the fields of immunology, hemophilia and Iten sivmedizin. The company was founded in 1983 and is headquartered in Langenfeld, Germany. | - |
Matthew Riordan | M | - |
Octapharma USA, Inc.
Octapharma USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Octapharma AG, Octapharma USA, Inc. develops and manufactures medicines for hematology, immunotherapy, and critical care patients. The company is based in Paramus, NJ. | - |
Jukka Tapani Lampinen | M | 69 |
Octapharma AB
Octapharma AB Pharmaceuticals: MajorHealth Technology Octapharma AB manufactures and distributes pharmaceutical products. Its products used for treatment in coagulation disorders, immune disease, and intensive care and emergency medicine. The company operates as a subsidiary of Octapharma AG. Octapharma was founded in 1997 and is located in Stockholm, Sweden. | - |
Gerold Theo Rempeters | M | - |
Octapharma AB
Octapharma AB Pharmaceuticals: MajorHealth Technology Octapharma AB manufactures and distributes pharmaceutical products. Its products used for treatment in coagulation disorders, immune disease, and intensive care and emergency medicine. The company operates as a subsidiary of Octapharma AG. Octapharma was founded in 1997 and is located in Stockholm, Sweden. | - |
Frederic Marguerre | M | - |
Octapharma AG
Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland. | - |
Marc Maltas | M | - |
Octapharma AG
Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland. | - |
Marlis Kueng | F | - |
Octapharma AG
Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland. | - |
Olaf Walter | M | - |
Octapharma USA, Inc.
Octapharma USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Octapharma AG, Octapharma USA, Inc. develops and manufactures medicines for hematology, immunotherapy, and critical care patients. The company is based in Paramus, NJ. | - |
Inger Antonsson | F | - |
Octapharma Nordic AB
Octapharma Nordic AB Pharmaceuticals: MajorHealth Technology Octapharma Nordic AB specializes in the production and distribution of plasma derivative. Its products are used for the treatment in coagulation disorders, immune disease and intensive care and emergency medicine. The company is headquartered in Stockholm, Sweden | - |
Norbert Müller | M | - |
Octapharma USA, Inc.
Octapharma USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Octapharma AG, Octapharma USA, Inc. develops and manufactures medicines for hematology, immunotherapy, and critical care patients. The company is based in Paramus, NJ. | - |
Daniel Wyder | M | - |
Octapharma AG
Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland. | - |
Matt Riordan | M | - |
Octapharma AG
Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Schweiz | 7 | 36,84% |
Schweden | 5 | 26,32% |
Vereinigte Staaten | 4 | 21,05% |
Deutschland | 2 | 10,53% |
Vereinigtes Königreich | 1 | 5,26% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Wolfgang Marguerre
- Persönliches Netzwerk